SELPERCATINIB Pharmacologic Class Indexing
- Class set ID
- 53ba9a2d-2814-4934-9eec-2f5c7e67a58b
- Version
- 1
- Effective date
- 20210726
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
| Label | Manufacturer | Effective | SPL version |
|---|---|---|---|
| These highlights do not include all the information needed to use RETEVMO safely and effectively. See full prescribing information for RETEVMO. RETEVMO ® (selpercatinib) capsules, for oral use RETEVMO ® (selpercatinib) tablets, for oral use Initial U.S. Approval: 2020 | Eli Lilly and Company | Loxo Oncology, Inc. | 20251120 | 22 |